403 Forbidden


nginx
403 Forbidden

403 Forbidden


nginx
Follow us:
403 Forbidden

403 Forbidden


nginx

Microsoft Pri0

Welcome to Microsoft Pri0: That's Microspeak for top priority, and that's the news and observations you'll find here from Seattle Times technology reporter Matt Day.

July 25, 2007 at 11:35 AM

Targeted Genetics shares tumble on stopped clinical trial

Targeted Genetics stock fell more than 20 percent today after the company interrupted clinical testing of its lead arthritis drug because of a patient’s illness.

As of 2:24 pm Eastern time, the Seattle-based company’s shares traded at $2.07, down 56 cents or 21.29 percent.

The company said late Tuesday that it had stopped trials of its tgAAC94 therapy after a patient became seriously ill. It’s unclear whether the adverse effects are related to the drug.

Comments | More in Biotechnology

COMMENTS

No personal attacks or insults, no hate speech, no profanity. Please keep the conversation civil and help us moderate this thread by reporting any abuse. See our Commenting FAQ.



The opinions expressed in reader comments are those of the author only, and do not reflect the opinions of The Seattle Times.


403 Forbidden

403 Forbidden


nginx
403 Forbidden

403 Forbidden


nginx